Pharmacovigilance
Risk management plan (RMP) for introduction of new medicinal product (including vaccines)
WHO “SMART” pharmacovigilance strategy
Proof-of-concept study through multi-country collaboration
Causes of adverse events following immunization
Information about rates of reactions to vaccines
Developing a global strategy for enhancing vaccine safety